CNTX — CONTEXT THERAPEUTICS INC

Ownership history in Blackstone Inc.  ·  7 quarters on record

This page tracks every 13F SEC filing in which Blackstone Inc. reported a position in CONTEXT THERAPEUTICS INC (CNTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2024 Q3)
Avg. % of fund
0.01%
First filed
2024 Q2
Last filed
2025 Q4
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 2,440,330 — 0% 0.01% $3.6M $1.47
2025 Q3 UNCHANGED 2,440,330 — 0% 0.01% $2.4M $0.97
2025 Q2 UNCHANGED 2,440,330 — 0% 0.01% $1.6M $0.65
2025 Q1 UNCHANGED 2,440,330 — 0% 0.01% $1.5M $0.61
2024 Q4 UNCHANGED 2,440,330 — 0% 0.01% $2.6M $1.05
2024 Q3 ADDED 2,440,330 +601,621 +32.7% 0.02% $4.8M $1.96
2024 Q2 INITIATED 1,838,709 — — 0.02% $3.7M —
% of Fund (quarterly)    CNTX price (monthly, adj. close)

Other funds also holding CNTX

As of 2025 Q4 — sorted by position size

Avidity Partners Management LP 3Y 2.33% GREAT POINT PARTNERS LLC 3Y 7Y 2.23% MPM BioImpact LLC 3Y 1.8% Blue Owl Capital Holdings LP 3Y 0.82% CAXTON CORP 3Y 7Y 0.63% Sio Capital Management, LLC 3Y 7Y 0.31% Deep Track Capital, LP 3Y 0.19% Velan Capital Investment Management LP 3Y 0.09% ADAR1 Capital Management, LLC 0.04% Clear Harbor Asset Management, LLC 3Y 7Y 0.01%
← Back to Blackstone Inc. Holdings